White House Stands By FDA’s Makary After Accusations He Slow-Walked Vital Review Of Abortion Drugs
WASHINGTON — The head of the Food and Drug Administration is facing heavy fire from the pro-life community amid reports that he slow-walked a review of abortion drugs promised by Health and Human Services Director Robert F.…
